A Challenging Case of Advanced Cardiac Sarcoidosis Refractory to Infliximab Therapy
A 35-year-old man with cardiac sarcoidosis developed persistent myocardial inflammation, worsening left ventricular function and recurrent sustained ventricular tachycardia despite corticosteroids, methotrexate and third-line infliximab. Infliximab was stopped after neutropenia and infection, and PET imaging continued to show active disease. With advanced heart failure and arrhythmias, clinicians recommended formal heart-transplant assessment; rituximab was discussed as a possible further treatment. The case highlights the need for ongoing multimodality imaging and close monitoring in refractory cardiac sarcoidosis.
أسلوب التغطيةإخباري
Primarily a clinical case report grounded in patient findings and medical literature, with cautious clinical interpretation.